Meeting
2023 ASCO Annual Meeting
Association of tumor-informed minimal residual disease (MRD) with clinical outcomes for muscle invasive bladder cancer (MIBC): A multicenter retrospective real-world analysis.
Authors
Ajitha Kommalapati
University of Alabama at Birmingham, Birmingham, AL
Ajitha Kommalapati , George Laliotis , Michael Glover , Grayce Selig , Revathi Kollipara , Tamara Mahmood , Sumit Shah , Christopher J. Hoimes , Tyler F. Stewart , Shruti Sharma , Meenakshi Malhotra , Natalia Pajak , Mark Calhoun , Adam ElNaggar , Minetta C. Liu , Arnab Basu , Matt D. Galsky , Alan Tan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3050)
DOI
10.1200/JCO.2023.41.16_suppl.3050
Abstract #
3050
Poster Bd #
248
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Clinical outcomes following termination of immunotherapy due to long-term benefit in MSI-H colorectal cancer.
First Author: Kristen Simmons
Poster
2019 Genitourinary Cancers Symposium
Association of next generation sequencing characteristics of MIBC specimens with clinical outcomes: The USC experience.
First Author: Arnab Basu
Poster
2018 Genitourinary Cancers Symposium
Post-chemotherapy PD-L1 expression correlates with clinical outcomes in Japanese bladder cancer patients treated with total cystectomy.
First Author: Yasuhiro Hashimoto
Poster
2013 Gastrointestinal Cancers Symposium
Prediction of clinical outcome in stage II and III colon cancer by a common gene variant in AXIN2.
First Author: Joanna Szkandera